Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AstraZeneca

Drug firm bosses call for price increases in Europe amid tariff uncertainty

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Evening Standard

Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal

Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.

MarketBeat

Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?

TRUMP TARIFFS: UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

The Guardian - UK

Scramble underway to stop Trump tariffs hitting Britain’s pharmaceutical industry

Donald Trump has warned tariffs on pharmaceuticals would come ‘in the not-too-distant future’

The Independent UK

UK scrambling to get Donald Trump to slash tariffs to zero, says minister as US threatens medicines levies

Tariffs on Britain’s pharmaceutical industry could deal a severe blow, potentially costing firms billions of pounds

Evening Standard

‘Game-changing’ breast cancer pill to be offered on NHS

The new treatment helps to slow or stop the spread of cancer cells

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

‘Gamechanging’ breast cancer pill to be offered on NHS in England and Wales

U-turn by medicines watchdog means about 3,000 women with advanced forms of disease could benefit each year

The Guardian - UK

‘Landmark moment’ as new pill approved for common type of advanced breast cancer

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move.

The Independent UK

Uganda’s boda boda bikes are deadly polluters: study models how going electric could save lives

In Uganda, motorcycles known as boda bodas are a key part of the transport system. The country has over 1.5 million boda bodas on the road, amounting to roughly 70% of all vehicles. Boda bodas are crucial in providing last mile transport for people and goods on short trips because…

The Conversation

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The Guardian - UK

Trump tariffs: Which UK sectors will be hit hardest?

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.

Evening Standard

How Beijing plans to bounce back against Trump’s tariffs

China’s president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and AstraZeneca.

The Conversation

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

Fortune

GSK could double CEO Emma Walmsley's pay to $27 million

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

Bored Panda

Yale Scientists Link Covid Vaccines To Alarming New Syndrome With Long-Term Effects

"It's like being drained of vitality." Scientists discovered a new syndrome linked to the COVID-19 vaccines that may cause persistent biological changes and chronic flu-like symptoms. The post Yale Scientists Link Covid Vaccines To Alarming New Syndrome With Long-Term Effects first appeared on Bored Panda.

Evening Standard

AstraZeneca boss takes home £15m pay packet after profits rise

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024.

Get all your
news in one place.

100's of premium titles.
One news app.

inkl

Why Most Pharma Startups Fail—And How Barbara Navarro Strategic Consulting is Turning Struggles into Success

The pharmaceutical and biotech industries are brimming with potential. From revolutionary cancer treatments to cutting-edge gene-editing breakthroughs, start-ups in this space have the power to transform medicine and save lives.

The Guardian - UK

AstraZeneca, Whitehall, and a failed £450m deal for the next generation in vaccines. What went wrong?

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

The Independent UK

Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate Devlin question why it fell through

The Independent UK

FTSE 100 notches new record after Bank of England cuts rates

London’s blue-chip index smashed through recent highs after experts said the Bank’s announcement gave it ‘a shot of adrenaline’.

The Independent UK

AstraZeneca ‘very disappointed’ after ditching £450m Liverpool vaccine site

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision.

The Guardian - UK

AstraZeneca ‘very disappointed’ over axed £450m Liverpool vaccine project

As drugmaker reports 38% jump in profits, CEO denies tension with UK government after Speke plant decision

The Guardian - UK

Blame ministers for AstraZeneca U-turn

Letters: As a health minister in the 1970s, David Owen writes, he would have been too close to industry to allow such a deal to fail

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.